Doug Ellenoff Tells Us Why The SEC Needs To Take Its Time With The JOBS Act

The Securities and Exchange Commission missed a deadline of July 4, 2012 to adopt rules lifting a general advertising ban for private securities offerings as a part of the JOBs Act.

Read more »

Delenex May Be First Therapeutic Company With Tissue Penetrant Antibodies

Delenex Therapeutics, a Swiss biotech in the Greater Zurich Area is developing antibodies to treat serious medical conditions with high unmet need.

Read more »

Why Life Science Companies May Explore Relocation to Zurich

As an anchor sponsor for OneMedForum NY 2012, The Greater Zurich Area AG will be hosting a workshop Thursday morning on “Entering Europe.”

Read more »

NYSE to Host OneMedForum Finance Reception 2011 July 11th

The networking reception at this historic venue will feature a special keynote in the board room of the Stock Exchange from David Weild IV, former NASDAQ Vice Chair.

Read more »

SIX Swiss Exchange Offers More Visibility and Detail

Marco Estermann, Head Issuer Relations of SIX Swiss Exchange in the Greater Zurich Area sat down with OneMedRadio to discuss the growth of the Swiss biotech sector and particularly different strategies this sector employs to raise capital.

Read more »

Twitter’s Top 10 Healthcare Journalists To Follow

Below, we list the top ten healthcare journalists on Twitter improving the quality, accuracy and visibility of health care reporting and writing.

Read more »

Jason Napodano Discusses the “Buzz Word” Regenerative Medicine and Why its a Hot Area in Biotech

Napodano, a senior biotech analyst for Zacks Investment Research discusses 4 regenerative medicine companies making headway in the space.

Read more »